Hot Topics

Transporting Bariatric Residents in the Post-Acute Setting

Cannabis Use Linked to Lower Dementia Risk

Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of Rejoyn™, the First Prescription Digital Therapeutic Authorized for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms

The Furor Over 8 AM Meetings